PARTNERS in PATIENT SAFETY Associated Pneumonia

Total Page:16

File Type:pdf, Size:1020Kb

PARTNERS in PATIENT SAFETY Associated Pneumonia International Healthcare >> Gregg Blesch Gregg Blesch Another U.S.-Israeli friendship Patient-safety collaboration seeks broader Middle East participation ulon Stacey is so excited about Web conferencing that you’d to warm up the frozen peace process.” wonder if he doesn’t get out much, which isn’t the case. So far appeals made to the medical directors of four Palestinian hos- He’s president and CEO of Poudre Valley Health Sys- pitals in the West Bank have been declined or unanswered, tem, which has two hospitals in northern Colorado and Reznikovich says. Rserves communities scattered into neighboring Wyoming and “No matter what is our personal opinion in our home, walking in Nebraska, and he has friends far from the Rocky Mountains. Stacey the hospital we think about the best for our patients, regardless if they and two friends and colleagues in Israel have enlisted a handful of are Arabs, Jews, Christians,” Reznikovich says. “As you can see in any their peers to work together across huge distances toward improv- Israeli hospital, there are patients from every belief. When they are ing healthcare in what they’ve named the International patients, they are patients.” Patient Safety Collaborative. Although he is ambitious in his belief that a shared health- “We’re learning things from each other from across con- care mission might budge an intractable political impasse, tinents,” Stacey says, recalling a recent Web conference on he’s also realistic about how the political climate could deter- hospital-acquired infections conducted with healthcare pro- mine whether such collaboration can happen. fessionals stretching from the West Coast of the U.S. “It’s 100 miles above your head and your capacity,” to Jerusalem. Reznikovich says. He adds, though, that the invitations “Just listening to them, I thought: ‘Holy mackerel! I think will continue to be made, and he hopes that the Palestin- we’ve got something here,’ ” Stacey says. “This was just a ian hospitals will be represented at a meeting in June to be dream a year ago or so.” held in Jerusalem. Anything resembling results remains many months Stacey: “This was Under the umbrella of the collaborative, two networks removed, but the collaboration’s progress has been substan- just a dream a year have been established. One targets hospital-acquired infec- tial. Two years ago Stacey, along with Shmuel Reznikovich, ago or so.” tions and the other is focused on medication errors, both administrator of Netanya (Israel) Geriatric Medical Center, using a model derived from the approach of the Institute for and Zvi Stern, director of the Mount Scopus campus of Hadassah Uni- Healthcare Improvement in the U.S. Each participant in a network has versity Hospital in Jerusalem, spotted an opportunity to receive grant written an aims statement, identified things that affect those drivers funding through the Binational Science Foundation, which supports and selected interventions. collaboration between U.S. and Israeli researchers. Each network also has a shared set of goals. For drug events, they They didn’t get the grant but decided to push ahead without fund- include implementing electronic error-reporting and improving use of ing with the groundwork they laid, and an inaugural face-to-face meet- automatic medication dispensers. For infections, they include improv- ing was held September 2008 in Jerusalem. ing handwashing compliance and cutting the incidence of infections The initial inspiration was to include Palestinian hospitals in the caused by particular strains of bacteria by 30% in one year. effort. Reznikovich says there were three underpinnings. The first two Now they’re measuring and sharing, working toward drawing are practical: Improve patient safety and do it without reinventing the some conclusions to share when they convene again in person in wheel by sharing knowledge. The third is hopeful: “Maybe we’ll be able Jerusalem in June 2010. After the current networks conclude, Poudre Valley Health System intends to administer a new one on ventilator- PARTNERS IN PATIENT SAFETY associated pneumonia. Organizations participating, so far, in the Virtually a meeting per month In the meantime, collaboration is happening remotely across many International Patient Safety Collaborative time zones. The networks meet virtually each month in formats that have Assuta Medical Center, Tel Aviv, Israel been evolving through trial and error, taking place early in the morning in the western U.S. and at 5 p.m. in Israel. The first meetings were via Chaim Sheba Medical Center, Tel Hashomer, Israel teleconferencing with spotty call quality and a disruptive moderator, Children's Hospital, Aurora, Colo. which proved particularly challenging as members struggled with one another’s accents (the meetings are conducted entirely in English). Hadassah University Medical Center, Jerusalem The discussions have evolved to combine the phone hookup with a Joint Commission International, Oak Brook, Ill. Web-based meeting place, allowing presenters to use visual materials, Kootenai Medical Center, Coeur d©Alene, Idaho and a test session with video conferencing is planned for February. Marly Christenson, system director of clinical transformation for Netanya (Israel) Geriatric Medical Center Seattle-based Providence Health & Services, agreed to administer the Poudre Valley Health System, Fort Collins, Colo. network on hospital-acquired infections, in effect absorbing four of the Providence Health & Services, Seattle Israeli hospitals into a project that was previously planned for the sys- tem, which owns or sponsors 24 hospitals in Alaska, California, Mon- St. Luke's Health System, Kansas City, Mo. tana, Oregon and Washington state. Shoham Geriatric Medical Center, Pardes Hanna, Israel “There’s an additional experience in this international collabora- tion that adds one more level of incentive and motivation—this sense Source: International Patient Safety Collaborative of really contributing globally to patient safety,” Christenson says. 32 Modern Healthcare • November 30, 2009.
Recommended publications
  • Conference Time Table
    CONFERENCE TIME TABLE 6 April 7-8, 2019, Hilton Tel Aviv Hotel The 48th Annual Meeting of the Israel Endocrine Society PROGRAM AT A GLANCE Sunday, April 7, 2019 15:30-15:50 Coffee Break 07:30-08:30 Registration and Gathering 15:50-16:50 Meet the Expert Hall A Meet the Expert Hall B Novel Avenues in the Management of Endocrine Hypertension 08:30-10:00 Parallel Oral Presentations Congenital Adrenal Hyperplasia Felix Beuschlein Thyroid Reproduction Obesity, Metabolic Syndrome Nils P Krone University Hospital of Zurich Chairs: Dania Hirsch, Chairs: Talia Geva Eldar, Chairs: Yonit Marcus- Perlman, Sheffield, UK Carlos Benbassat Joseph Orly Rosane Abramof-Ness 16:50-17:30 IES Members General Assembly Hall A Hall A Hall B Hall C Executive Committee Report 10:00-10:20 Coffee Break Accountant Report 10:20-11:20 Poster Session Poster Hall Prize lectures Hall A 11:20-12:10 Chair: Avraham Karasik Lindner Prize, Eyal Robenshtok Chowers Prize, Yael Riahi Outstanding Community Physician Award, Elizabeta Baron Plenary lecture 1 Hall A Fat in the Blood, Fat in the Heart 12:10-13:00 Ira Goldberg, NYU School of Medicine, NYU Langone Health Chair: Hannah Kanety 13:00-14:00 Lunch 14:00-15:30 Parallel Symposia Symposium 1 Hall A Symposium 2 Hall B Congenital Adrenal Hyperplasia (CAH) Big Data – Digital Health in in 2019 Endocrinology Chairs: Naomi Weintrob, David Zangen Chairs: Moshe Phillip, Irit Hochberg 14:00-14:30 Nils P Krone Varda Shalev Molecular Pathogenesis of Rare Forms Big Data: From Research to Value of CAH Director of research and innovation institute Academic Unit of Child Health Maccabi and Morris Kahn.
    [Show full text]
  • Silicone Breast Implants and the Risk of Autoimmune/Rheumatic Disorders: a Real-World Analysis
    Silicone breast implants and the risk of autoimmune/rheumatic disorder... 31.08.2020, 07:22 Silicone breast implants and the risk of autoimmune/rheumatic disorders: a real-world analysis Abdulla Watad, Vered Rosenberg, Gabriel Chodick and Howard Amital authors share equal contribution. Article Navigation Abdulla Watad, Department of Medicine ‘B’, Sheba Medical Center, Tel-Hashomer, Israel The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel Search for other works by this author on: Vered Rosenberg, Epidemiology and Database Research, Maccabi Healthcare Services, Tel Aviv, Israel Search for other works by this author on: Shmuel Tiosano, Department of Medicine ‘B’, Sheba Medical Center, Tel-Hashomer, Israel The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel https://academic.oup.com/ije/article/47/6/1846/5133598 1 von 34 Silicone breast implants and the risk of autoimmune/rheumatic disorder... 31.08.2020, 07:22 Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel Search for other works by this author on: Jan Willem Cohen Tervaert, Jan Willem Cohen Tervaert Division of Rheumatology, Department of Medicine and Dentistry, University of Alberta, Edmonton, Canada Department of Medicine and Immunology, University of Maastricht, Maastricht, The Netherlands Search for other works by this author on: Yarden Yavne, Department of Medicine ‘B’, Sheba Medical Center, Tel-Hashomer, Israel The Zabludowicz
    [Show full text]
  • When Are Foreign Volunteers Useful? Israel's Transnational Soldiers in the War of 1948 Re-Examined
    This is a repository copy of When are Foreign Volunteers Useful? Israel's Transnational Soldiers in the War of 1948 Re-examined. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/79021/ Version: WRRO with coversheet Article: Arielli, N (2014) When are Foreign Volunteers Useful? Israel's Transnational Soldiers in the War of 1948 Re-examined. Journal of Military History, 78 (2). pp. 703-724. ISSN 0899- 3718 Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ promoting access to White Rose research papers Universities of Leeds, Sheffield and York http://eprints.whiterose.ac.uk/ White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/79021/ Paper: Arielli, N (2014) When are foreign volunteers useful? Israel's transnational soldiers in the war of 1948 re-examined. Journal of Military History, 78 (2). 703 - 724. White Rose Research Online [email protected] When are Foreign Volunteers Useful? Israel’s Transnational Soldiers in the War of 1948 Re-examined Nir Arielli Abstract The literature on foreign, or “transnational,” war volunteering has fo- cused overwhelmingly on the motivations and experiences of the vol- unteers.
    [Show full text]
  • Curriculum Vitae Shay Schneider, M.D
    April, 2020 Curriculum Vitae Shay Schneider, M.D Name: Shay Schneider Date of birth: December 23, 1979 Place of birth: Tel Aviv, Israel Family status: Married +2 Telephone: +972-54-7685189 E mail: [email protected] CLINICAL EXPERIENCE Sep 2018-present: Senior staff member Otolaryngology department, Soroka University Medical Center, Beer Sheva, Israel. Sep 2018-Sep 2020: Clinical Fellow (Rhinology and skull base surgery), A.R.M, Center of Otolaryngology/ Head and Neck Surgery, Assuta Medical Center, Tel Aviv, Israel. Sep 2012-Sep 2018: Resident: Otolaryngology department, Soroka University Medical Center, Beer Sheva, Israel. Jan 2011 - Jan 2012: Rotating internship year: Training physician in internal medicine, general surgery, anesthesia and pediatrics units, Barzilai Medical Center in Ashkelon, Israel. Jun 2009 - Aug 2009: Clinical rotation in Otolaryngology, Shaare Zedek Medical Center in Jerusalem, Israel. ACADEMIC DEGREES 2016- present: Instructor, Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel. 2004-2010: MD degree, Third Medical Faculty, Charles University in Prague (English program), Czech Republic. POST ACADEMIC COURSES Jan 2020: Baloon sinuplasty and Eustachian tuboplasty, Madeira, Portugal. Aug-Sep 2018: Observership, University of Texas MD Anderson Cancer Center, Houston, Texas. United States 2013-2018: School of Continuing Studies, Otolaryngology program, The Sackler Faculty of Medicine, Tel Aviv University, Israel. June 2017: Rhinoplasty course, Ziv Medical Center, Israel Feb 2017: 4th Annual OSAS International Surgery Course, Florida Hospital Nicholson Center & Florida Hospital Celebration Health, Celebration, United States. Feb 2017: Trans- oral laser surgery (TLS) course, Kaplan Medical Center. Sep 2016: Head and neck dissection course, Tel Aviv University. Oct 2014: Sedation course, Sheba Medical Center, Tel Aviv.
    [Show full text]
  • Prospective Longitudinal Trends in Body Composition and Clinical Outcomes 3 Years Following Sleeve Gastrectomy
    Obesity Surgery (2019) 29:3833–3841 https://doi.org/10.1007/s11695-019-04057-2 ORIGINAL CONTRIBUTIONS Prospective Longitudinal Trends in Body Composition and Clinical Outcomes 3 Years Following Sleeve Gastrectomy Shiri Sherf-Dagan1,2,3 & Shira Zelber-Sagi1,4 & Assaf Buch5,6 & Nir Bar1,2 & Muriel Webb1 & Nasser Sakran7,8,9 & Asnat Raziel7 & David Goitein2,7,10 & Andrei Keidar11 & Oren Shibolet1,2 Published online: 11 July 2019 # Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Background and Aims Longitudinal assessment of body composition following bariatric surgery allows monitoring of health status. Our aim was to elucidate trends of anthropometric and clinical outcomes 3 years following sleeve gastrectomy (SG). Methods A prospective cohort study of 60 patients who underwent SG. Anthropometrics including body composition analysis measured by multi-frequency bioelectrical impedance analysis, blood tests, liver fat content measured by abdominal ultrasound and habitual physical activity were evaluated at baseline and at 6 (M6), 12 (M12), and 36 (M36) months post-surgery. Results Sixty patients (55% women, age 44.7 ± 8.7 years) who completed the entire follow-up were included. Fat mass (FM) was reducedsignificantly1yearpost-surgery(55.8±11.3to26.7±8.3kg;P < 0.001) and then increased between 1 and 3 years post- operatively, but remained below baseline level (26.7 ± 8.3 to 33.1 ± 11.1 kg; P < 0.001). Fat free mass (FFM) decreased significantly during the first 6 months (64.7 ± 14.3 to 56.9 ± 11.8 kg; P < 0.001), slightly decreased between M6 and M12 and then reached a plateau through M36.
    [Show full text]
  • The Peres Center for Peace, Tel-Aviv April 12Th, 2019
    April 12th, 2019 The Peres Center for Peace, Tel-Aviv BREAST CANCER INNOVATIONS The Israeli Society for Clinical Oncology and Radiation Therapy and Roche are Pleased to Invite You to an Enriching and Educating Meeting with our Distinguished Guest Speaker: Prof. Charles E. Geyer Please Send the Attached Registration Form to A.M Knasim No Later than April 1st 2019 E-mail: [email protected] Tel: 03-6081520 Fax: 03-6081522 Prof. Charles E. Geyer Friday, 12th April 2019 • Professor of Medicine 08:00-09:00 Welcome Reception • Harrigan, Haw, Luck Families Chair in Cancer Research 09:00-09:10 Opening Remarks • Virginia Commonwealth University, Massey Dr. Noa Efrat Ben-Baruch Cancer Center Head, Israeli Breast Cancer Group • Associate Director of Clinical Research Head, Department of Oncology Kaplan Medical Center Charles E. Geyer, Jr. is Professor of Medicine and the Harrigan, Haw, Luck Families Chair in Cancer Research at Virginia Commonwealth University Massey Chairmen: Dr. Georgeta Fried Cancer Center, an NCI-designated Cancer Center. He serves as Associate Director Head Breast Cancer Unit of Clinical Research for the Massey Cancer Center with oversight responsibility Rambam Medical Center for all cancer-related clinical research activities within the Center. Prof. Geyer Dr. Margarita Tokar has devoted most of his academic career on the design and conduct of multi- institutional, phase III clinical trials in breast cancer with a particular focus on Senior Oncologist the development of HER2 targeted therapies. He has served in several leadership Soroka University Medical Center positions for multi-institution research initiatives. These include vice-chair of the 09:10-09:30 Personalized Nanothechnologies in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Committee Management of Breast Cancer from 1999 until 2007, Associate Director of Medical Affairs from 2002 to 2006 and Director of Medical Affairs for NSABP from 2006 to 2011.
    [Show full text]
  • Governing Hospitals
    The Israel National Institute for Health Policy Research GOVERNINGGOVERNING HOSPITALSHOSPITALS INTERNATIONAL WORKSHOP REPORT Editor: Shlomo Mor-Yosef MARCH 2011, HAIFA, ISRAEL Graphic design: Nava Moscko Production: Zisman, Shiber GOVERNING HOSPITALS Dear Colleagues, Increasing market and regulatory pressures impose on hospitals all over the world important strategic challenges to the scope and quality of services rendered, cost control, equity and resource acquisition and allocation, financial stability, and many others. The following questions often rise: Are the current forms of hospital governance suitable to face these challenges? Should "philanthropic" hospitals, with a volunteer board, adopt a more active and critical form of governance typically found in the "corporate" model? Who should man the Board of Directors? Should legal and economic considerations prevail over professional and ethical ones? Should the hospital CEO be a doctor or a "professional" manager? The comprehensive study on “Governing Public Hospitals in Europe” conducted by Richard Saltman, Antonio Duran, David Chinitz and others in the European Observatory on Health Systems served as an initiator to this workshop. In Israel we have 4 different major forms of hospital governance facing the same doubts and soul searching. In this workshop, the heads of Israel’s health system, hospital directors and academicians deliberated these basic questions regarding hospital governance in great depth. This book comes to summarize the principle methods and various models for managing hospitals. Prof. Shlomo Mor-Yosef Chairman, Board of Directors The Israel National Institute for Health Policy Research 3 INTERNATIONAL WORKSHOP Table of Contents Page 1. Abstracts 7 2. Presentations 17 a. Governing Public Hospitals - An International Perspective Richard B.
    [Show full text]
  • Asuta Medical Release Form Request
    Asuta Medical Release Form Request Conjoint Christos engrosses that jubilee bull coyly and machicolated inurbanely. Gelatinous and overfar Marty travelling while unlovable hatfulWeidar stably. whiffle her Turkic whereunto and attitudinize substitutively. Indivertible Stephan never girdings so thermoscopically or falsifies any Log back shall your account. Additional meals and more open your privacy is not damage to cancel a specialization asuta medical release form request. Shaping agriculture around his world. Two patients who owns all authors asuta medical release form request. Our button with Assuta furthers our traction in the healthcare space, blank we do forward to helping more organizations like Assuta secure their critical systems and data. Furthermore LH release cab been demonstrated to swallow a beneficial effect on the. To sale more about this produce, you or the doctor may contact the county research staff using the contacts provided below. After our prepared remarks, we will open we call before your questions. They roll with patients from let over their world including Europe, the UK and the United States. Clalit tends to target a specialization in english asuta medical release form request timed out by using ultrasound to remove it? The sausage stage of treatment may own three options. Springer Nature remains neutral with hope to jurisdictional claims in published maps and institutional affiliations. This process of the israeli data, asuta medical release form request on the fax number associated with surgery? Tel Aviv never stops. All authors read and approved the final manuscript. But often suffer from israeli women asuta medical release form request new types of food places.
    [Show full text]
  • APF Newsletter, Winter 2006 – 2007
    Winter 2006-2007 APF A Newsletter of the From The President AmericanEmergency Physicians andFellowship Disaster Preparednessfor Medicine in Israel Course News in Israel From The President Israel in Crisis Mission August 2006 would like to share with our members and donors the important by Dr. Dan Moskowitz I APF activities of the past 6 months. his past August, I had the privilege of being invited to par- 1. APF ISRAEL CRISIS FUND REPORT After placing on our T ticipate in an Emergency APF Mission to Israel with APF website and sending a special crisis appeal from Dr. Danny Laor, Board members Drs. Mike Frogel, Paul Liebman and Charles the Deputy Minister for Emergency Preparedness, on the critical Kurtzer. Dr. Boaz Tadmor organized an incredible, whirlwind needs of the Northern hospitals, it was very gratifying indeed that over $100,000 tour for us, only two days after the cessation of hostilities in was received for our Crisis Fund. All of this will be distributed to hospitals such as Israel. We were provided with a unique glimpse of the Israeli Sieff Hospital in Safed, Poriya in Tiberias, Western Galilee Medical Center in Nahariya, and Rambam Medical Center in Haifa, with the hospital CEO’s given the healthcare system under stress, including face-to-face meet- discretion as to how best to utilize these funds to help their hospital in light of the ings with top healthcare officials, as well as visits to the trau- recent crisis. matized hospitals in northern Israel. Perhaps most importantly, we visited 2. MISSION TO ISRAEL Three APF Board members, Drs.
    [Show full text]
  • YEHUDA SHOENFELD, MD, FRCP(Hon.)
    YEHUDA SHOENFELD, M.D., FRCP(Hon.) CURRICULUM VITAE 2013 Chaim Sheba Medical Center The Zabludowicz Center for Autoimmune Diseases Tel Hashomer 52621, Israel Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Sackler Faculty of Medicine, Tel-Aviv University, Israel. Tel: 03-5302661 Fax: 03-5352855 E-mail: [email protected] - 2 - CURRICULUM VITAE YEHUDA SHOENFELD, M.D. Date and place of birth: February 14, 1948, Slovakia. Marital Status: Married + 3 (Nettea, Amir, Guy) EDUCATION 1965 - 1972 Hadassa Medical School, Hebrew University, Jerusalem 1972 - M.D. Thesis: "Osteogenesis Imperfecta" (Advisor: Prof. A. Fried) cum laude 1976 - 1978 Diploma cum laude upon completion of post graduate studies in internal medicine, Postgraduate Medical School, Tel Aviv University 1976 - Senior resident, Department of Internal Medicine "D" and Out-Patient Clinic of Hematology and Immunology, Beilinson Medical Center, Petach Tikva, Israel 1978 (3m) - Clinical Fellowship, Hematology/Oncology, Department of Hematology, City of Hope, Duarte, California (Director: Prof. E. Beutler) 1979 (3m) - Clinical Fellowship Hematology/Oncology, Tufts New England Medical Center, Boston, Mass. (Director: Prof. Robert S. Schwartz) 1980 (3m) - Clinical Fellowship Hematology/Oncology, Cornell Medical Center, New York Hospital (Director: Prof. R. Nachman) 1980 - Master in Internal Medicine, Postgraduate Medical School, Tel-Aviv University 1983 - 1984 Senior Physician, department of Internal Medicine "D", Beilinson Medical Center, Petach Tikva, Israel 1985 - Head, Department of Medicine "D" and Outpatient Clinic for Clinical Immunology and Allergy, Soroka Medical Center, Beer-Sheva, Israel 1985 - Head of the Hybridoma Unit and Research Laboratory for Autoimmune Diseases, Soroka Medical Center, and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel 1989 - Head of Department of Medicine "B" Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel-Aviv University, Israel.
    [Show full text]
  • A Preclinical Animal Study of a Novel, Simple, and Secure Duct and Vessel Occluder for Laparoscopic Surgery
    Surgical Endoscopy and Other Interventional Techniques https://doi.org/10.1007/s00464-018-6052-0 A preclinical animal study of a novel, simple, and secure duct and vessel occluder for laparoscopic surgery Amir Szold1 · Arnold Miller2 · Nir Lilach3 · Ana‑Maria Botero‑Anug4 · Raanan Miller2 · Steven D. Schwaitzberg5 Received: 1 August 2017 / Accepted: 11 January 2018 © Springer Science+Business Media, LLC, part of Springer Nature 2018 Abstract Background Secure occlusion of large blood vessels and ductal structures is critical to all surgeries and remains a challenge in many minimally invasive procedures. This study compares in vivo use of the Amsel Occluder (AO) for secure laparoscopic blood vessel and duct closure, with one of the many commercially available hemoclips (Ligaclip®), in the porcine model. Methods Laparoscopic closure of vessels and ducts was performed on 12 swine to compare the ease of use, safety and effi- cacy of the AO with a hemoclip, as well as the tissue response at > 30 days (10 swine). All vessels and ducts were occluded and then transected between the occluding clips. Any bleeding or leakage was noted. In the chronic study, confirmation of satisfactory vessel occlusion post nephrectomy was determined by laparotomy as well as by contrast angiography and venography. The tissue response and healing was evaluated by a histopathological study for the effects of any biological incompatibilities. Results In the acute laparoscopic study, a total of 24 occlusions between 2 and 10 mm were performed with the AO (n = 19) and hemoclip (n = 5). In the chronic study, 5 nephrectomies (AO n = 3, hemoclip N = 2) and 5 cholecystectomies (AO n = 3, hemoclip n = 2) were performed with survival ranging from 42 to 72 days.
    [Show full text]
  • Dasatinib Response in Acute Myeloid Leukemia Is Correlated with FLT3 /ITD, PTPN11 Mutations and a Unique Gene Expression Signature
    Acute Myeloid Leukemia SUPPLEMENTARY APPENDIX Dasatinib response in acute myeloid leukemia is correlated with FLT3 /ITD, PTPN11 mutations and a unique gene expression signature Sigal Tavor, 1 Tali Shalit, 2 Noa Chapal Ilani, 3 Yoni Moskovitz, 3 Nir Livnat, 3 Yoram Groner, 4 Haim Barr, 2 Mark D. Minden, 5,6,7,8 Alexander Plotnikov, 2 Michael W. Deininger, 9,10 Nathali Kaushansky 3,# and Liran I. Shlush 3,5,11,# 1Hemato-Oncology Department, Assuta Medical Center, Tel Aviv, Israel; 2G-INCPM, Weizmann Institute of Science, Rehovot, Israel; 3De - partment of Immunology, Weizmann Institute of Science, Rehovot, Israel; 4Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel; 5Princess Margaret Cancer Centre, University Health Network Toronto, Ontario, Canada; 6Department of Med - ical Biophysics, University of Toronto, Toronto, Ontario, Canada; 7Department of Medicine, University of Toronto, Toronto, Ontario, Canada; 8Division of Medical Oncology and Hematology, University Health Network, Toronto, Ontario, Canada; 9Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA; 10 Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA and 11 Division of Hematology, Rambam Healthcare Campus, Haifa, Israel #NK and LIS contributed equally as co-senior authors. ©2020 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol. 2019.240705 Received: October 16, 2019 Accepted: April 30, 2020. Pre-published: May 21, 2020. Correspondence: LIRAN I. SHLUSH - [email protected] Supplementary Methods Drugs library The 46 drugs cover a broad range of pathways and mechanisms of action. A large group of drugs which we tested are FLT3 targeted tyrosine kinase inhibitors, a common mutation with adverse prognosis in AML.
    [Show full text]